Pharma Microbiology Testing Kits Global Market Report 2022: Featuring Abbott, Boston Analytics, ThermoFisher, F. Hoffmann-La Roche & Others - ResearchAndMarkets.com
The global pharma microbiology testing kits market is expected to grow from $5.12 billion in 2021 to $5.66 billion in 2022 at a compound annual growth rate (CAGR) of 10.7%. The market is expected to grow to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%
DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--
The "Pharma Microbiology Testing Kits Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global pharma microbiology testing kits market is expected to grow from $5.12 billion in 2021 to $5.66 billion in 2022 at a compound annual growth rate (CAGR) of 10.7%. The market is expected to grow to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%.
The rise in the incidence of infectious diseases is one of the prime drivers of the pharma microbiology testing kits market. According to CDC (Centre for Disease Control and Prevention), infectious diseases such as Hepatitis A, B, and C, sexually transmitted diseases (STDs), and human immunodeficiency virus (HIV) are increasing their prevalence globally.
